Mirati Therapeutics, Inc. (MRTX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
ASSETS
Current assets
Cash and cash equivalents	235.3	413.1	885.6	46.5	32.7	107.7	22.4	49.5
Short-term investments	848.6	1,078.3	504.5	368.5	190.1	43.1	34.4	72.8
Accounts receivable, net	0.9
Inventory	3.0
Other current assets	21.2	16.6	13.5	9.4	5.7	4.9	2.8	3.1
Total current assets	1,109.0	1,508.0	1,403.6	424.4	226.7	155.8	59.6	125.4
Property and equipment, net	17.5	15.8	7.8	1.8	0.5	0.5	0.6	0.6
Intangible asset, net	14.9
Long-term investment	3.5	8.2	15.6
Right-of-use asset	36.1	37.7	39.9	0.6
Other long-term assets	21.6	19.0	9.2	5.4	1.3	1.0	3.3	2.0
Total assets	1,202.6	1,588.8	1,476.1	432.2	228.5	157.2	63.4	128.0

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Accounts payable	38.9	35.2	18.1
Accrued liabilities	120.6	108.5	53.4
Total current liabilities	159.4	143.7	71.5	48.9	26.1	13.6	15.0	9.8
Lease liability	43.7
Other liabilities	3.0	2.2	2.0	1.0	0.6	0.3	0.1	0.0
Total liabilities	206.1	191.7	115.3	49.9	26.9	14.0	15.1	9.8

Commitments and contingencies (see Note 11)
Shareholders' equity
Common stock	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	3,453.1	3,099.9	2,481.2	1,144.7	751.1	594.4	428.5	415.2
Accumulated other comprehensive loss	-3.7	9.1	9.8	9.9	9.5	9.5	9.5	9.6
Accumulated deficit	-2,452.9	-1,712.0	-1,130.2	-772.3	-559.0	-460.6	-389.8	-306.6
Total shareholders' equity	996.5	1,397.0	1,360.8	382.3	201.6	143.3	48.3	118.2
Total liabilities and shareholders' equity	1,202.6	1,588.8	1,476.1	432.2	228.5	157.2	63.4	128.0